Cite
APA Citation
Collins, G., Noy, A., de Vos, S., Thieblemont, C., Martin, P., Flowers, C., Morschhauser, F., Ma, S., Coleman, M., Peles, S., Smith, S., Barrientos, J., Smith, A., Munneke, B., Dimery, I., Beaupre, D., & Chen, R. (n.d.). safety and efficacy of single‐agent ibrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL): A multicenter, open‐label, phase 2 study. Hematological oncology, 35, 211–212. http://access.bl.uk/ark:/81055/vdc_100047414719.0x000030